57 related articles for article (PubMed ID: 24846306)
1. Post-transplant lymphoproliferative disorder in pediatric liver transplant recipients: Experience from a South African transplant center.
Walabh P; Moore DP; Hajinicolaou C
Transpl Infect Dis; 2024 Apr; 26(2):e14221. PubMed ID: 38152054
[TBL] [Abstract][Full Text] [Related]
2. Primary sclerosing cholangitis and other risk factors for post-transplant lymphoproliferative disease after liver transplantation in adults.
Ruijter BN; Tushuizen ME; van der Helm D; Hew M; Reeven M; Vossen ACTM; Metselaar HJ; Alwayn IPJ; Dubbeld J; Polak WG; van Hoek B
Liver Transpl; 2024 Jun; 30(6):640-646. PubMed ID: 37698933
[TBL] [Abstract][Full Text] [Related]
3. Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation.
Rausch L; Koenecke C; Koch HF; Kaltenborn A; Emmanouilidis N; Pape L; Lehner F; Arelin V; Baumann U; Schrem H
Transplant Res; 2016; 5():6. PubMed ID: 27486513
[TBL] [Abstract][Full Text] [Related]
4. Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation.
Iwamoto T; Monma F; Fujieda A; Nakatani K; Gayle AA; Nobori T; Katayama N; Okuda M
Ther Drug Monit; 2015 Oct; 37(5):581-8. PubMed ID: 25565672
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cells.
Cilião HL; Ribeiro DL; Camargo-Godoy RB; Specian AF; Serpeloni JM; Cólus IM
Exp Toxicol Pathol; 2015 Feb; 67(2):179-87. PubMed ID: 25541063
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
7. A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.
Stevens RB; Foster KW; Miles CD; Lane JT; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Nielsen KJ; Skorupa JY; Kellogg AM; Malik T; Wrenshall LE
Transplantation; 2015 Jan; 99(1):197-209. PubMed ID: 25083614
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic disease after liver transplantation: Focus on de novo neoplasms.
Burra P; Rodriguez-Castro KI
World J Gastroenterol; 2015 Aug; 21(29):8753-68. PubMed ID: 26269665
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr viral load as a tool to diagnose and monitor post-transplant lymphoproliferative disease.
Gärtner BC; Fischinger J; Schäfer H; Einsele H; Roemer K; Müller-Lantzsch N
Recent Results Cancer Res; 2002; 159():49-54. PubMed ID: 11785844
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and post-transplant lymphoproliferative disease.
Holmes RD; Sokol RJ
Pediatr Transplant; 2002 Dec; 6(6):456-64. PubMed ID: 12453197
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation.
Fukushima D; Sato K; Kawagishi N; Ohuchi N; Satomi S
Transplantation; 2015 Jan; 99(1):114-9. PubMed ID: 24846306
[TBL] [Abstract][Full Text] [Related]
12. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.
Schaffer K; Hassan J; Staines A; Coughlan S; Holder P; Tuite G; McCormick AP; Traynor O; Hall WW; Connell J
Liver Transpl; 2011 Dec; 17(12):1420-6. PubMed ID: 21837744
[TBL] [Abstract][Full Text] [Related]
14. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
[TBL] [Abstract][Full Text] [Related]
15. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]